Search results (6)
« Back to NewsOxford scientists capture genome’s structure in unprecedented detail
5 November 2025
RDM scientists have achieved the most detailed view yet of how DNA folds and functions inside living cells, revealing the physical structures that control when and how genes are switched on.
Clinical trials begin for a first-in-class, inhaled gene therapy for people with cystic fibrosis
25 February 2025
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.
New MRC Centre to create cutting-edge gene therapies
11 December 2024
Professor Deborah Gill is to co-lead an MRC research centre being launched to develop new advanced treatments for currently untreatable diseases.
Transformative treatments for children with fatal genetic lung diseases
15 November 2024
AlveoGene, a company co-founded by two of our scientists, today moves closer to approval of its novel inhaled gene therapy for a rare deficiency which causes fatal respiratory distress syndrome in newborns.
Experts outline priority areas which should be addressed to advance treatment for inherited lung diseases
29 July 2024
An expert group including Deborah Gill, Professor of Gene Medicine in RDM’s Nuffield Division of Clinical Laboratory Sciences, has published a new position paper which addresses the gaps in research and treatment development for familial pulmonary fibrosis (FPF) – a collection of individually rare and severe genetically inherited lung diseases.